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Background
Component-resolved diagnosis has been shown to
improve diagnosis of food allergy. The aim of this study
was to evaluate whether component-resolved diagnosis
may help to identify patients at risk of severe allergic
reactions to hazelnut.
Methods
A total of 161 hazelnut-sensitized patients were
included: 40 children and 15 adults with objective symp-
toms in DBPCFC and 24 adults with a convincing severe
history were compared to 41 children and 41 adults
with no or subjective symptoms in DBPCFC (grouped
together). IgE levels to hazelnut extract and single com-
ponents were analyzed with ImmunoCAP.
Results
IgE to hazelnut extract was significantly higher in
children with severe than with no or mild symptoms.
Sensitization to rCor a 1.04 was common among both
children and adults, while sensitization to rCor a 8 was
rare. In 13% of children and 49% of adults with a severe
hazelnut allergy, only sensitization to rCor a 1.04 was
observed and not to other water-soluble allergens. Sensi-
tization to nCor a 9 and/or rCor a 14 was strongly asso-
ciated with a severe hazelnut allergy. Using adapted cut-
off levels, a diagnostic discrimination between severity
groups was obtained. IgE to either nCor a 9 ≥1 kUA/L
or rCor a 14 ≥5 kUA/L (children) and IgE to either
nCor a 9 ≥1 kUA/L or rCor a 14 ≥1 kUA/L (adults) had
a specificity of >90% and accounted for 83% of children
and 44% of adults with a severe hazelnut allergy.
Conclusion
Sensitization to Cor a 9 and Cor a 14 is highly specific
for patients with objective symptoms in DBPCFC as
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